Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Survival: 19.5 months
Toxicity Grade: 5
Treatments: Chemotherapy
Drugs: Methotrexate
Country: Italy
City/State/Province: Milan
Hospital: Fondazione IRCCS Istituto Nazionale dei Tumori
Journal: Link
Date: 6/2014

This study involved 157 metastatic urothelial cancer patients with a median age of 60 years. No gender information was provided.

Patients were treated with the chemotherapy regimen called MVAC, which consists of methotrexate, vinblastine, doxorubicin, and cisplatin.

There were two treatment-related deaths due to sepsis (infection). Grade 3-4 neutropenia, thrombocytopenia, and mucosal inflammation were also reported.

The median overall survival was 19.5 months.

Correspondence: Dr. Andrea Necchi; email:

E-mail to a Friend Email Physician More Information